Improving tools to detect early signs of oral cancer
Advancing On-Slide and Optical Biopsy Tools to Detect High-Risk Oral Premalignancy
['FUNDING_U01'] · UNIVERSITY OF TX MD ANDERSON CAN CTR · NIH-11122794
This study is working on better ways to spot early signs of serious mouth conditions that could lead to cancer, using new techniques to help doctors make more accurate diagnoses, so patients can get the right treatment without having to come back for check-ups as often.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TX MD ANDERSON CAN CTR (nih funded) |
| Locations | 1 site (HOUSTON, UNITED STATES) |
| Trial ID | NIH-11122794 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing diagnostic tools to identify high-risk oral premalignant conditions, such as oral epithelial dysplasias and oral lichen planus. By utilizing advanced on-slide and optical biopsy techniques, the project aims to improve the accuracy of early detection, which is crucial for effective treatment. The study will analyze the biological characteristics of these lesions to better understand their progression to cancer, ultimately aiming to reduce the need for frequent follow-ups that are currently challenging for patients. Through this innovative approach, the research seeks to provide more reliable diagnostic methods for clinicians.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with oral epithelial dysplasias or oral lichen planus who are at risk of developing oral cancer.
Not a fit: Patients with confirmed oral cancer or those without any premalignant lesions may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate detection of oral cancers, improving treatment outcomes and survival rates for patients.
How similar studies have performed: Previous research has shown promise in using advanced diagnostic technologies for early cancer detection, indicating that this approach could be effective.
Where this research is happening
HOUSTON, UNITED STATES
- UNIVERSITY OF TX MD ANDERSON CAN CTR — HOUSTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEI, YU LEO — UNIVERSITY OF TX MD ANDERSON CAN CTR
- Study coordinator: LEI, YU LEO
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.